Ancilia Biosciences
PrivateLast Round
Seed
Apr 6, 2026
Total Funding Raised
$7.73M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Ancilia Biosciences is a biotechnology company developing a new class of live biotherapeutics and other microbial products with immunity to key viral pathogens by harnessing the natural power of CRISPR.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ancilia Biosciences Comparables
Compare Ancilia Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Concerto Biosciences | 71% | |
| Eligo Bioscience | 71% | |
| Vedanta Biosciences | 67% |
Ancilia Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Apr 6, 2026 | ||||
| Grant | Oct 23, 2024 | ||||
| Grant | Oct 23, 2024 | ||||
| Seed | Jul 17, 2024 | ||||
| Grant | Aug 1, 2021 |
Key People
Founding team and executive leadership
Ancilia Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Metaplanet Holdings | Seed |
| NIH RADx | Grant |
| National Institute of Diabetes and Digestive and Kidney Diseases | Grant |
| Safar Partners | Seed |
| National Institute of Diabetes and Digestive and Kidney Diseases | Grant |
| Spacecadet Ventures | Seed |
| Zubi Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors grew 464% MoM, from 286 to 1.6K.
- Apr 6, 2026
$10M Seed Round raised.
Ancilia Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Ancilia Biosciences's valuation, stock price, and market status.
Is Ancilia Biosciences a public or private company?
Ancilia Biosciences is a private company.
What is the current stock price of Ancilia Biosciences?
Ancilia Biosciences is a private company with no public stock price. No recent secondary market data is available.
How much is Ancilia Biosciences worth (valuation)?
Valuation information for Ancilia Biosciences is not publicly available.
Can I buy Ancilia Biosciences stock?
Ancilia Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Ancilia Biosciences's last funding round?
Ancilia Biosciences's most recent funding round was Seed Round on April 6, 2026.
Who are the main investors in Ancilia Biosciences?
Key investors in Ancilia Biosciences include Safar Partners.
Will Ancilia Biosciences IPO soon?
No public IPO plans have been announced for Ancilia Biosciences.
How can I track Ancilia Biosciences secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Ancilia Biosciences's secondary market activity and sign up for updates.